Randomized Study of Optimal Subcutaneous Injection Strategy for COR-1167 in Chronic Heart Failure

The primary objective is to identify the optimal subcutaneous injection strategy for chronic heart failure, with the aim of determining the most suitable approach for clinical use. No secondary objectives are specified.

The sponsor did not provide information on the total number of participants or the trial population selection. The available description indicates inclusion of both healthy volunteers of both sexes, with an age range corresponding to 3 to 17 years. No additional information was provided regarding general health status, lifestyle considerations, or key inclusion or exclusion criteria.

This phase 3 clinical trial is a randomized study in healthy participants designed to identify the optimal subcutaneous injection strategy for COR-1167. The overall trial duration is planned from May 2026 to October 2026. The study includes a screening visit to assess eligibility and confirm inclusion criteria before enrollment. Participants who meet eligibility requirements then enter the trial period and undergo the assigned study procedures according to the randomization plan. Follow-up visits are performed to monitor study participation and collect relevant trial data. An end-of-study visit is conducted at completion of participation to finalize assessments. The expected length of participant involvement is limited to the individual study period within the overall trial timeline. Early termination may occur if eligibility is not confirmed, if a participant withdraws, or if discontinuation is required for other protocol-defined reasons.

No investigational medicinal products or comparator treatments were specified in the source data. No pharmaceutical form, dosage, route of administration, frequency of administration, dosing schedule, or compliance monitoring information was provided.

Chronic heart failure efficacy will be assessed within the clinical trial using the study-defined efficacy parameters and analysis methods specified in the protocol.